InMed Pharmaceuticals Inc. logo

InMed Pharmaceuticals Inc. (INM)

Market Open
12 Jun, 13:48
NASDAQ (CM) NASDAQ (CM)
$
1. 55
-0.03
-1.8987%
$
2.82M Market Cap
- P/E Ratio
- Div Yield
686 Volume
0 Eps
$ 1.58
Previous Close
Investors:
Add Transaction
Day Range
1.5 1.59
Year Range
0.57 5.5
Want to track INM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

InMed Pharmaceuticals Inc. (INM) Statistics

Valuation metrics

Market Cap 2.82M
Enterprise value -1.88M
Trailing P/E (ttm) -0.65
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 0.71
Price/Book (mrq) 0.93
Enterprise Value/Revenue -0.47
Enterprise Value/EBITDA 0.2

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 123.79K
Average volume (90 days) 1.67M

Price summary

52-Week low 0.57
52-Week high 5.5
Beta -
50-Day moving average 1.05
200-Day moving average 1.02

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 15 Nov 2024

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -2.46%
Operating margin -2.47%

Operational effectiveness

Return on assets -1.09%
Return on equity -0.73%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 0.99
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.45
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1.28
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 3.11%
Book value per share (mrq) 1.7

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -